Virani, S. S. et al. Heart disease and stroke statistics—2021 update. Circulation 143, E254–E743 (2021).
Roger, V. L. Epidemiology of heart failure. Circ. Res. 113, 646 (2013).
Wu, T. et al. Minimal evidence of transdifferentiation from recipient bone marrow to parenchymal cells in regenerating and long-surviving human allografts. Am. J. Transpl. 3, 1173–1181 (2003).
Tang, X. L. et al. Long-term outcome of administration of c-kitPOS cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, structural and functional improvement and proliferation of endogenous cells persist for at least one year. Circ. Res. 118, 1091 (2016).
Rosenbloom, J., Mendoza, F. A. & Jimenez, S. A. Strategies for anti-fibrotic therapies. Biochim. Biophys. Acta. 1832, 1088–1103 (2013).
Denton, C. P. et al. Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum. 56, 323–333 (2007).
Mohindra, P. & Desai, T. A. Micro- and nanoscale biophysical cues for cardiovascular disease therapy. Nanomed. Nanotechnol. Biol. Med. 34, 102365 (2021).
Souders, C. A., Bowers, S. L. K. & Baudino, T. A. Cardiac fibroblast: the renaissance cell. Circ. Res. 105, 1164 (2009).
Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E. & Blaxall, B. C. Cardiac Fibrosis. Circ. Res. 118, 1021–1040 (2016).
Ayala, P., Lopez, J. I. & Desai, T. A. Microtopographical cues in 3D attenuate fibrotic phenotype and extracellular matrix deposition: implications for tissue regeneration. Tissue Eng. Part A 16, 2519 (2010).
Allen, J. et al. Tunable microfibers suppress fibrotic encapsulation via inhibition of TGFβ signaling. Tissue Eng. Part A 22, 142 (2016).
Pinney, J. R. et al. Discrete microstructural cues for the attenuation of fibrosis following myocardial infarction. Biomaterials 35, 8820 (2014).
Le, L. V. et al. Injectable hyaluronic acid-based microrods provide local micromechanical and biochemical cues to attenuate cardiac fibrosis after myocardial infarction. Biomaterials 169, 11–21 (2018).
Peña, J. R., Pinney, J. R., Ayala, P., Desai, T. A. & Goldspink, P. H. Localized delivery of mechano-growth factor E-domain peptide via polymeric microstructures improves cardiac function following myocardial infarction. Biomaterials 46, 26–34 (2015).
Rivera, K. O. et al. Localized delivery of β-NGF via injectable microrods accelerates endochondral fracture repair. Front. Bioeng. Biotechnol. 2023.05.22. https://doi.org/10.3389/fbioe.2023.1190371 (2023).
Neri, M., Riezzo, I., Pascale, N., Pomara, C. & Turillazzi, E. Ischemia/reperfusion injury following acute myocardial infarction: a critical issue for clinicians and forensic pathologists. Mediators Inflamm. 2017, 7018393 (2017).
Verma, S. et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 105, 2332–2336 (2002).
Takawale, A. et al. Myocardial recovery from ischemia-reperfusion is compromised in the absence of tissue inhibitor of metalloproteinase 4. Circ. Hear. Fail. 7, 652–662 (2014).
van der Pol, A., van Gilst, W. H., Voors, A. A. & van der Meer, P. Treating oxidative stress in heart failure: past, present and future. Eur. J. Heart Fail 21, 425–435 (2019).
Jugdutt, B. I. & Jugdutt, B. A. Role of oxidative stress in myocardial ischemia and infarction. Oxidative Stress Hear. Dis. 325–362 https://doi.org/10.1007/978-981-13-8273-4_14/TABLES/3 (2019).
Wang, R. M. et al. Myocardial matrix hydrogel acts as a reactive oxygen species scavenger and supports a proliferative microenvironment for cardiomyocytes. Acta Biomater. 152, 47–59 (2022).
Wang, S. et al. Preservation of cardiac functions post myocardial infarction in vivo by a phenylboric acid-grafted hyaluronic hydrogel with anti-oxidation and accelerated degradation under oxidative microenvironment. Compos. Part B Eng. 238, 109941 (2022).
Talman, V. & Ruskoaho, H. Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration. Cell Tissue Res. 365, 563 (2016).
Hinderer, S. & Schenke-Layland, K. Cardiac fibrosis—A short review of causes and therapeutic strategies. Adv. Drug Deliv. Rev. 146, 77–82 (2019).
Yue, T. et al. Multifunctional biomaterial platforms for blocking the fibrosis process and promoting cellular restoring effects in myocardial fibrosis therapy. Front. Bioeng. Biotechnol. 10, 1544 (2022).
Diaz, M. D. et al. Injectable myocardial matrix hydrogel mitigates negative left ventricular remodeling in a chronic myocardial infarction model.JACC Basic Transl.Sci. 6, 350–361 (2021).
Kalamajski, S. & Oldberg, A. The role of small leucine-rich proteoglycans in collagen fibrillogenesis. Matrix Biol. 29, 248–253 (2010).
Reese, S. P., Underwood, C. J. & Weiss, J. A. Effects of decorin proteoglycan on fibrillogenesis, ultrastructure, and mechanics of type I collagen gels. Matrix Biol. 32, 414–423 (2013).
Iwasaki, S. et al. The modulation of collagen fibril assembly and its structure by decorin: an electron microscopic study. Arch. Histol. Cytol. 71, 37–44 (2008).
Raspanti, M., Viola, M., Sonaggere, M., Tira, M. E. & Tenni, R. Collagen fibril structure is affected by collagen concentration and decorin. Biomacromolecules 8, 2087–2091 (2007).
Rada, J. A., Cornuet, P. K. & Hassell, J. R. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp. Eye Res. 56, 635–648 (1993).
Yamaguchi, Y., Mann, D. M. & Ruoslahti, E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346, 281–284 (1990).
Hildebrand, A. et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J. 302, 527–534 (1994).
Hill, L. J. et al. Sustained release of decorin to the surface of the eye enables scarless corneal regeneration. NPJ Regen. Med. 3, 23 (2018).
Alan, C., Kocoglu, H., Altintas, R., Alici, B. & Ersay, A. R. Protective effect of decorin on acute ischemia-reperfusion injury in the rat kidney. Arch. Med. Sci. 7, 211–216 (2011).
Faust, S. M., Lu, G., Wood, S. C. & Bishop, D. K. Transforming growth factor β neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection. J. Immunol. 183, 7307 (2009).
Li, L. et al. Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction. Am. J. Physiol. Heart Circ. Physiol. 297, H1504–H1513 (2009).
Zhang, Z. et al. Recombinant human decorin inhibits TGF-β1-induced contraction of collagen lattice by hypertrophic scar fibroblasts. Burns 35, 527–537 (2009).
Mohan, R. R., Gupta, R., Mehan, M. K., Cowden, J. W. & Sinha, S. Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts. Exp. Eye Res. 91, 238–245 (2010).
Kwan, P., Ding, J. & Tredget, E. E. MicroRNA 181b regulates decorin production by dermal fibroblasts and may be a potential therapy for hypertrophic scar. PLoS One 10, e0123054–e0123054 (2015).
Özay, R. et al. Does decorin protect neuronal tissue via its antioxidant and antiinflammatory activity from traumatic brain injury? an experimental study. World Neurosurg. 97, 407–415 (2017).
Du, S., Shao, J., Xie, D. & Zhang, F. Decorin inhibits glucose-induced lens epithelial cell apoptosis via suppressing p22phox-p38 MAPK signaling pathway. PLoS One 15, e0224251 (2020).
Santra, M. et al. Protection of adult mouse progenitor cells and human glioma cells by de novo decorin expression in an oxygen- and glucose-deprived cell culture model system. J. Cereb. Blood Flow. Metab. 26, 1311–1322 (2006).
Gerdes, A. M. & Capasso, J. M. Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure. J. Mol. Cell. Cardiol. https://doi.org/10.1016/0022-2828(95)90000-4 (1995).
Le, L. V., Mkrtschjan, M. A., Russell, B. & Desai, T. A. Hang on tight: reprogramming the cell with microstructural cues. Biomed. Microdevices 21, 43 (2019).
Kharbikar, B. N., Mohindra, P. & Desai, T. A. Biomaterials to enhance stem cell transplantation. Cell Stem Cell 29, 692–721 (2022).
Slevin, M. et al. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol. 26, 58–68 (2007).
Yang, C. et al. The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J. Biol. Chem. 287, 43094 (2012).
Gao, F., Yang, C. X., Mo, W., Liu, Y. W. & He, Y. Q. Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing. Clin. Investig. Med. 31, E106–E116 (2008).
Abdalla, S., Makhoul, G., Duong, M., Chiu, R. C. J. & Cecere, R. Hyaluronic acid-based hydrogel induces neovascularization and improves cardiac function in a rat model of myocardial infarction. Interact. Cardiovasc. Thorac. Surg. 17, 767 (2013).
Hemshekhar, M. et al. Emerging roles of hyaluronic acid bioscaffolds in tissue engineering and regenerative medicine. Int. J. Biol. Macromol. 86, 917–928 (2016).
Wang, Y., Han, G., Guo, B. & Huang, J. Hyaluronan oligosaccharides promote diabetic wound healing by increasing angiogenesis. Pharmacol. Rep. 68, 1126–1132 (2016).
Takeuchis, Y., Kodama, Y. & Matsumoto, T. Bone matrix decorin binds transforming growth factor+ and enhances its bioactivity*. J. Biol. Chem. 269, 3263632638 (1994).
Gubbiotti, M. A., Vallet, S. D., Ricard-Blum, S. & Iozzo, R. V. Decorin interacting network: a comprehensive analysis of decorin-binding partners and their versatile functions. Matrix Biol. 55, 7 (2016).
Weis, S. M. et al. A role for decorin in the remodeling of myocardial infarction. Matrix Biol. 24, 313–324 (2005).
Hao, J. et al. Elevation of Expression of Smads 2, 3, and 4, Decorin and TGF-βin the Chronic Phase of Myocardial Infarct Scar Healing. J. Mol. Cell. Cardiol. 31, 667–678 (1999).
Yan, W. et al. Decorin gene delivery inhibits cardiac fibrosis in spontaneously hypertensive rats by modulation of transforming growth factor-β/smad and p38 mitogen-activated protein kinase signaling pathways. Hum. Gene. Ther. 20, 1190–1200 (2009).
Scott, P. G., Grossmann, J. G., Dodd, C. M., Sheehan, J. K. & Bishop, P. N. Light and X-ray scattering show decorin to be a dimer in solution. J. Biol. Chem. 278, 18353–18359 (2003).
Yang, Y., Yu, W. W., Yan, W. & Xia, Q. Decorin induces cardiac hypertrophy by regulating the CaMKII/MEF-2 signaling pathway in vivo. Curr. Med. Sci. 2021 415 41, 857–862 (2021).
Miska, E. A. et al. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18, 5099–5107 (1999).
Backs, J., Song, K., Bezprozvannaya, S., Chang, S. & Olson, E. N. CaM kinase II selectively signals to histone deacetylase four during cardiomyocyte hypertrophy. J. Clin. Invest. 116, 1853 (2006).
Youn, H. D., Grozinger, C. M. & Liu, J. O. Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. J. Biol. Chem. 275, 22563–22567 (2000).
Black, B. L. & Cripps, R. M. Myocyte enhancer factor 2 transcription factors in heart development and disease. Hear. Dev. Regen. 673–699. https://doi.org/10.1016/B978-0-12-381332-9.00030-X (2010).
Cornwell, J. D. & McDermott, J. C. MEF2 in cardiac hypertrophy in response to hypertension. Trends Cardiovasc. Med. https://doi.org/10.1016/J.TCM.2022.01.002 (2022).
Passier, R. et al. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105, 1395 (2000).
Rodell, C. B. et al. Injectable shear-thinning hydrogels for minimally invasive delivery to infarcted myocardium to limit left ventricular remodeling. Circ. Cardiovasc. Interv. 9, e004058 (2016).
Ifkovits, J. L. et al. Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc. Natl Acad. Sci. USA 107, 11507–11512 (2010).
So, J. Y. et al. Regeneration of ischemic heart using hyaluronic acid-based injectable hydrogel. J. Biomed. Mater. Res. Part B Appl. Biomater. 91B, 163–171 (2009).
Springer, M. L. et al. Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle. Mol. Ther. 7, 441–449 (2003).
Tous, E. et al. Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling. Biomacromolecules 12, 4127–4135 (2011).
Chajara, A. et al. Increased hyaluronan and hyaluronidase production and hyaluronan degradation in injured aorta of insulin-resistant rats. Arterioscler. Thromb. Vasc. Biol. 20, 1480–1487 (2000).
Chung, C., Beecham, M., Mauck, R. L. & Burdick, J. A. The influence of degradation characteristics of hyaluronic acid hydrogels on in vitro neocartilage formation by mesenchymal stem cells. Biomaterials 30, 4287–4296 (2009).
Burdick, J. A. & Prestwich, G. D. Hyaluronic Acid Hydrogels for Biomedical Applications. Adv. Mater. 23, H41–H56 (2011).
Dedkov, E. I. et al. Sex-related differences in intrinsic myocardial properties influence cardiac function in middle-aged rats during infarction-induced left ventricular remodeling. Physiol. Rep. 4, e12822 (2016).
Dedkov, E. I., Oak, K., Christensen, L. P. & Tomanek, R. J. Coronary vessels and cardiac myocytes of middle-aged rats demonstrate regional sex-specific adaptation in response to postmyocardial infarction remodeling. Biol. Sex. Differ. 5, 1–14 (2014).
Biondi-Zaccai, G. G. L. et al. Reduced post-infarction myocardial apoptosis in women: a clue to their different clinical course? Heart 91, 99 (2005).
Wu, J. C., Nasseri, B. A., Bloch, K. D., Picard, M. H. & Scherrer-Crosbie, M. Influence of sex on ventricular remodeling after myocardial infarction in mice. J. Am. Soc. Echocardiogr. 16, 1158–1162 (2003).
Litwin, S. E., Katz, S. E., Litwin, C. M., Morgan, J. P. & Douglas, P. S. Gender differences in postinfarction left ventricular remodeling. Cardiology 91, 173–183 (1999).
Bencherif, S. A. et al. Influence of the degree of methacrylation on hyaluronic acid hydrogels properties. Biomaterials 29, 1739–1749 (2008).
Richbourg, N. R. & Peppas, N. A. The swollen polymer network hypothesis: quantitative models of hydrogel swelling, stiffness, and solute transport. Prog. Polym. Sci. 105, 101243 (2020).
Tsanaktsidou, E., Kammona, O. & Kiparissides, C. On the synthesis and characterization of biofunctional hyaluronic acid based injectable hydrogels for the repair of cartilage lesions. Eur. Polym. J. 114, 47–56 (2019).
Spearman, B. S. et al. Tunable methacrylated hyaluronic acid-based hydrogels as scaffolds for soft tissue engineering applications. J. Biomed. Mater. Res. – Part A 108, 279–291 (2020).
Haxaire, K., Braccini, I., Milas, M., Rinaudo, M. & Pérez, S. Conformational behavior of hyaluronan in relation to its physical properties as probed by molecular modeling. Glycobiology 10, 587–594 (2000).
Mihardja, S. S. et al. The effect of a peptide-modified thermo-reversible methylcellulose on wound healing and LV function in a chronic myocardial infarction rodent model. Biomaterials 34, 8869–8877 (2013).
Mihardja, S. S. et al. Targeted in vivo extracellular matrix formation promotes neovascularization in a rodent model of myocardial infarction. PLoS One https://doi.org/10.1371/journal.pone.0010384. (2010).
Springer, M. L. et al. Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography. Am. J. Physiol. – Hear. Circ. Physiol. 289, 1307–1314 (2005).
van der Wal, S. et al. scikit-image: image processing in Python. PeerJ 2, e453 (2014).
Bradski, G. The OpenCV Library. Dr. Dobb’s Journal: Softw. Tools Prof. Program. 25, 120–123 (2000).
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.nature.com/articles/s41536-023-00336-w